CRH Medical (CRH Medical) EBIT per Share : $-0.40 (TTM As of Dec. 2020)

View and export this data going back to 2008. Start your Free Trial

What is CRH Medical EBIT per Share?

CRH Medical's EBIT per Share for the three months ended in Dec. 2020 was $-0.33. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2020 was $-0.40.

During the past 12 months, the average EBIT per Share Growth Rate of CRH Medical was -145.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for CRH Medical's EBIT per Share or its related term are showing as below:

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of CRH Medical was 125.10% per year. The lowest was -53.20% per year. And the median was 23.80% per year.

CRHM's 3-Year EBIT Growth Rate is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 5.9
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

CRH Medical's EBIT for the three months ended in Dec. 2020 was $-23.2 Mil.

CRH Medical EBIT per Share Historical Data

The historical data trend for CRH Medical's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CRH Medical EBIT per Share Chart

CRH Medical Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

EBIT per Share

Get a 7-Day Free Trial

0.33

0.40

0.26

0.18

-0.40

CRH Medical Quarterly Data
	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20
EBIT per Share	Get a 7-Day Free Trial															0.05	-0.04	-0.05	0.01	-0.33

CRH Medical EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

CRH Medical's EBIT per Share for the fiscal year that ended in Dec. 2020 is calculated as

	EBIT per Share		(A: Dec. 2020 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-28.572	/	71.535
=	-0.40

CRH Medical's EBIT per Share for the quarter that ended in Dec. 2020 is calculated as

	EBIT per Share		(Q: Dec. 2020 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-23.193	/	71.466
=	-0.32

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.40

CRH Medical (AMEX:CRHM) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

CRH Medical EBIT per Share Related Terms

Thank you for viewing the detailed overview of CRH Medical's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

CRH Medical (CRH Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CRH Medical Corp (AMEX:CRHM) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

999 Canada Place, Suite 578, World Trade Center, Vancouver, BC, CAN, V6C 3E1

Website

https://www.crhsystem.com

CRH Medical Corp is a healthcare products and services company. The company, through its subsidiaries, provides anesthesiology services to gastroenterologists in the United States. It also specializes in the treatment of hemorrhoids utilizing its treatment protocol and patented proprietary technology. The company's product, the CRH O'Regan System, is a single-use, disposable, hemorrhoid treatment. It distributes the CRH O'Regan System, treatment protocols, operational and marketing services directly to gastroenterologists. Geographically, the company operates in the United States and Canada, of which key revenue is derived from the United States.

Executives

Richard Bear	officer: Chief Financial Officer	9062 NE 37TH PLACE, BELLEVUE WA 98004
Ian Webb	director	7385 LABURNUM ST VANCOUVER A1 V6P 5N2
James Kreger	officer: President	2580 ACORN AVE NE ATLANTA GA 30305
Tushar M Ramani	director, officer: Chief Executive Officer	118 TALAVERA PLACE PALM BEACH GARDENS FL 33418
Brian T Griffin	director
Todd Patrick	director	9029 NE 36TH STREET, BELLEVUE WA 98004
David Allan Johnson	director	7464 NORTH SHORE ROAD NORFOLK VA 23505
Anthony F Holler	director	8855 NORTHBROOK CT BURNABY A1
Edward Wright	officer: Chief Financial Officer	2992 WEST 31ST AVE VANCOUVER A1 V6L 2A4